These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1615556)

  • 21. Mitochondrial DNA genotyping reveals synchronous nature of simultaneously detected endometrial and ovarian cancers.
    Guerra F; Kurelac I; Magini P; Cormio A; Santini D; Ceccarelli C; Gasparre G
    Gynecol Oncol; 2011 Aug; 122(2):457-8. PubMed ID: 21592547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recommendations for the management of women with an increased genetic risk of gynaecological cancer].
    Verheijen RH; Boonstra H; Menko FH; de Graaff J; Vasen HF; Kenter GG
    Ned Tijdschr Geneeskd; 2002 Dec; 146(50):2414-8. PubMed ID: 12518519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinico-genetical studies of colonic cancer. II. Genetic analysis of predisposition to colonic cancer].
    Belev NF; Gar'kavtseva RF; Samotyia EE; Trubnikov VI; Gindilis VM
    Genetika; 1986 Oct; 22(10):2512-8. PubMed ID: 3792839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium.
    Shannon C; Kirk J; Barnetson R; Evans J; Schnitzler M; Quinn M; Hacker N; Crandon A; Harnett P
    Clin Cancer Res; 2003 Apr; 9(4):1387-92. PubMed ID: 12684409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial cancer prevalence spanning eight years. Family N.
    Lynch HT
    Arch Intern Med; 1974 Nov; 134(5):931-8. PubMed ID: 4441203
    [No Abstract]   [Full Text] [Related]  

  • 26. Scale-up technology: moving predictive tests for inherited breast, ovarian, and colon cancers from the bench to the bedside and beyond.
    Holtzman NA
    J Natl Cancer Inst Monogr; 1995; (17):95-7. PubMed ID: 8573464
    [No Abstract]   [Full Text] [Related]  

  • 27. [The relative risk of a multiple primary cancer occurrence].
    Okamoto N; Morio S; Suzuki T
    Gan No Rinsho; 1989 Feb; 35(3):348-54. PubMed ID: 2926982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinics for counseling on cancer genetics. Experiences with genetic studies and counseling on familial breast cancer and colorectal cancer].
    Gerdes AM; Rasmussen K; Graversen HP; Kronborg O; Qvist N; Holm NV; Axelsson CK; Rose C; Ahrons S; Dyreborg U; Hørder M
    Ugeskr Laeger; 1998 Feb; 160(8):1145-51. PubMed ID: 9492624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis.
    Go RC; King MC; Bailey-Wilson J; Elston RC; Lynch HT
    J Natl Cancer Inst; 1983 Sep; 71(3):455-61. PubMed ID: 6577220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic testing for breast and ovarian cancer susceptibility: a family experience.
    Van Riper M; McKinnon WC
    J Midwifery Womens Health; 2004; 49(3):210-9. PubMed ID: 15134674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer.
    Vahteristo P; Ojala S; Tamminen A; Tommiska J; Sammalkorpi H; Kiuru-Kuhlefelt S; Eerola H; Aaltonen LA; Aittomäki K; Nevanlinna H
    J Med Genet; 2005 Apr; 42(4):e22. PubMed ID: 15805151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
    Olsen JH; Seersholm N; Boice JD; Krüger Kjaer S; Fraumeni JF
    Br J Cancer; 1999 Feb; 79(3-4):673-9. PubMed ID: 10027348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancer.
    Ramus SJ; Elmasry K; Luo Z; Gammerman A; Lu K; Ayhan A; Singh N; McCluggage WG; Jacobs IJ; Whittaker JC; Gayther SA
    Clin Cancer Res; 2008 Sep; 14(18):5840-8. PubMed ID: 18794095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Family studies of malignant melanoma and associated cancer.
    Lynch HT; Frichot BC; Lynch P; Lynch J; Gurigis HA
    Surg Gynecol Obstet; 1975 Oct; 141(4):517-22. PubMed ID: 1166375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes.
    Machado PM; Brandão RD; Cavaco BM; Eugénio J; Bento S; Nave M; Rodrigues P; Fernandes A; Vaz F
    J Clin Oncol; 2007 May; 25(15):2027-34. PubMed ID: 17513806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Legal and ethical issues in genetic testing and counseling for susceptibility to breast, ovarian and colon cancer.
    Dickens BM; Pei N; Taylor KM
    CMAJ; 1996 Mar; 154(6):813-8. PubMed ID: 8634959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Familial cancer. Initial results of an inquiry into its occurrence in Basel].
    Müller H; Bürki N; Gencik A; Gencikova A; Kovacs E; Roth M; Trächslin N; Voegtli B; Weber W
    Soz Praventivmed; 1985; 30(1):28-32. PubMed ID: 2858143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Foreword.
    Ashley SW
    Curr Probl Surg; 2010 Oct; 47(10):742. PubMed ID: 20816138
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.